MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 27.12.2025
Biophytis SA EV/EBITDA 2011-2026 | BPTS
EV/EBITDA Jährlich Biophytis SA
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -17.6 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -17.6 | -17.6 | -17.6 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-0.271 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.984 | - | 1.35 % | $ 17.8 M |  China |
 |
Amphastar Pharmaceuticals
AMPH
|
11.2 | $ 16.95 | -2.02 % | $ 792 M |  USA |
 |
AgeX Therapeutics
AGE
|
-0.164 | - | -10.17 % | $ 12.2 K | USA |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B |  France |
 |
AstraZeneca PLC
AZN
|
3.06 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-0.593 | $ 7.45 | -4.85 % | $ 204 M |  Israel |
 |
Athira Pharma
ATHA
|
0.0485 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
8.55 | - | 0.74 % | $ 768 M | Israel |
 |
Galera Therapeutics
GRTX
|
2.25 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
0.204 | - | -18.52 % | $ 27.3 M | Britain |
 |
AbCellera Biologics
ABCL
|
-6.16 | $ 4.1 | -6.82 % | $ 1.22 B | Canada |
 |
Compugen Ltd.
CGEN
|
-7.07 | $ 2.82 | -6.93 % | $ 263 M | Israel |
 |
Coherus BioSciences
CHRS
|
-1.86 | $ 1.57 | -3.68 % | $ 184 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-2.4 | $ 1.58 | -0.94 % | $ 420 M | Britain |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
BioNTech SE
BNTX
|
-12.2 | $ 89.3 | -2.92 % | $ 21.6 B | Germany |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.0315 | - | - | $ 231 M | USA |
 |
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
0.0726 | $ 3.38 | -3.15 % | $ 5.56 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-0.963 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-1 | $ 0.74 | 0.4 % | $ 33.8 M | Israel |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Esperion Therapeutics
ESPR
|
19.2 | $ 3.13 | 0.32 % | $ 651 M | USA |
 |
Aptose Biosciences
APTO
|
1.65 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Eton Pharmaceuticals
ETON
|
187 | $ 30.34 | 1.27 % | $ 816 M | USA |
 |
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Exelixis
EXEL
|
18.1 | $ 49.79 | -2.56 % | $ 13.5 B | USA |
 |
AlloVir
ALVR
|
1.19 | - | 4.14 % | $ 49.1 M | USA |
 |
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-316 | $ 21.68 | 0.51 % | $ 2.76 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | USA |
 |
Fortress Biotech
FBIO
|
-1.74 | $ 2.4 | 4.13 % | $ 67 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
|
Forte Biosciences
FBRX
|
-3.97 | $ 22.78 | -4.92 % | $ 295 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
-26.6 | $ 9.59 | 3.73 % | $ 274 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | USA |